Growth Metrics

Greater Cannabis Company (GCAN) Change in Accured Expenses (2017 - 2022)

Greater Cannabis Company's Change in Accured Expenses history spans 6 years, with the latest figure at $20000.0 for Q4 2022.

  • For Q4 2022, Change in Accured Expenses rose 160.91% year-over-year to $20000.0; the TTM value through Dec 2022 reached $60000.0, up 230.32%, while the annual FY2025 figure was $1627.0, 92.85% down from the prior year.
  • Change in Accured Expenses reached $20000.0 in Q4 2022 per GCAN's latest filing, roughly flat from $20000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $55977.0 in Q4 2019 to a low of -$55000.0 in Q1 2019.
  • Average Change in Accured Expenses over 5 years is $8366.9, with a median of $10062.5 recorded in 2020.
  • Peak YoY movement for Change in Accured Expenses: tumbled 3614.38% in 2019, then soared 4377.61% in 2022.
  • A 5-year view of Change in Accured Expenses shows it stood at -$24141.0 in 2018, then soared by 331.88% to $55977.0 in 2019, then crashed by 71.42% to $16000.0 in 2020, then tumbled by 305.22% to -$32836.0 in 2021, then soared by 160.91% to $20000.0 in 2022.
  • Per Business Quant, the three most recent readings for GCAN's Change in Accured Expenses are $20000.0 (Q4 2022), $20000.0 (Q3 2022), and -$10000.0 (Q2 2022).